“Additional Effect of Bhadradi Asthapan with Amrutadya Tail Anuvasan Basti and Kanchanar Guggul in primary hypothyroidism

“Add On Effect of Bhadradi Asthapan with Amrutadya Tail Anuvasan Basti and Kanchanar Guggul in Primary Hypothyroidism on Zulewsk’s Scale: A Randomised Control Trial ?

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/047855

Enrollment

Registered

2022-12-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having clinical features of hypothyroidism and fulfilling diagnostic criteria of this study. 2. Patients who are fulfilling the criteria of borderline hypothyroidism (2 to 5), clinical hypothyroidism (more than 5) according to Zulewsk’s scale. 3. Patients who are willing to participate in trial and ready to give written consent. 4. Patient having TSH value 4.6- 40mIu/L . 5. Patients of either sex, aged between 16-70 years irrespective of caste, religion, socio economic and educational status. 6. Those patients who are fit for Basti as per classics. 7. Patient with controlled HTN (BP Systolic

Exclusion criteria

Exclusion criteria: 1.Patients who are not willing to participate in trial and not ready to give written consent. 2.Patients having age below 16 years and above 70 years. 3.Patients who has uncontrolled HTN (BP Systolic >150 Diastolic > 90 mmHg), DM (FBS >130 mg/dl and PMBS > 200 mg/dl) or any other systemic illness. 4.Patients who are suffering from congenital hypothyroidism, neoplasia, toxic goitre. 5.Pregnent and lactating ladies. 6.Patients who are currently participating in any other clinical trial from last 6 months. 7. Patients who had undergone any type of Thyroid surgery 8.Patients who are unfit for Basti according to classis. 9.Patients on prolonged medication ( >6 week) with corticosteroids or any drug that may had an influence on the outcome of study.

Design outcomes

Primary

Measure	Time frame
Assessment (BT) on preceding day on Zulewsks scale Deepan-Pachan for 3-5 days First assessment on 4th day Amrutadya tail Anuvasan basti Bhadradi Asthapan Basti for 16 days second assessment on 17th day Kanchanar Guggul 500 mg-1gm Final assessment after completion subsequently for 45 days of treatment (on 45thday) Timepoint: 45 days	—

Secondary

Measure	Time frame
1.To evaluate the effect of Bhadradi Asthapan Basti with Amrutadya Tail Anuvasan Basti and Kanchanar Guggul with levothyroxine in primary hypothyroidism specifically on Billewicz diagnostic index. 2.To evaluate the effect of Bhadradi Asthapan Basti with Amrutadya Tail Anuvasan Basti and Kanchanar Guggul with levothyroxine in Primary hypothyroidism specifically on TSH. Timepoint: 45 days	—

Countries

India

Contacts

Public ContactMadhuri Raju Yawalkar

Government Ayurved College and Hospital,Nagpur

ashish.thatere@gmail.com9423406821

Outcome results